Oral Cancers Completed Phase 2 Trials for Cetuximab (DB00002)

Also known as: Cancer of the Mouth / Cancer of the Oral Cavity / Oral Cancer / Oral Cavity Cancer / Cancer of Mouth / Oral Cavity Neoplasm / Malignant Oral Cavity Neoplasm / Cancer, Mouth / Malignant oral cavity neoplasms / Mouth Cancer / Oral neoplasm malignant / Malignant neoplasm of mouth, unspecified / Primary malignant neoplasm of mouth (disorder) / Malignant tumor of oral cavity (disorder) / Malignant neoplasm of mouth NOS (disorder) / Lip and/or oral cavity cancer NOS / Lip and/or oral cavity cancer

IndicationStatusPhase
DBCOND0031962 (Oral Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01440270Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal CancerTreatment
NCT00933387A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell CarcinomaTreatment
NCT00462735Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck CancerTreatment